CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease

Hepato-Gastroenterology

Volumn 52, Issue 63, 2005, Pages 808-811

  Griga, Thomas ^a   Klein, Wolfram ^b   Epplen, Jorg T ^b   Hebler, Ute ^a   Stachon, Axel ^a   May, Burkard ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

CD14 polymorphism; Crohn's disease

Indexed keywords

CD14 ANTIGEN; CD14 RECEPTOR; CELL RECEPTOR; ENDOTOXIN; GENOMIC DNA; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANTIGENS, CD14; CROHN DISEASE; DISEASE SUSCEPTIBILITY; FEMALE; GENE EXPRESSION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, IMMUNOLOGIC; STATISTICS;

EID: 20644443295     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wright S, Ramos R, Tobias R, Ulevitch R, Mathison J: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249:1431-1433.
2. Bazil V, Horejsi V, Baudys M, Kristofova H, Strominger J, Kostka V, Hilgert I: Biochemical characterization of a soluble form of the 53 kDa monocyte surface antigen. Eur J Immunol 1986; 16:1583-1589.
3. Antal-Szalmas P: Evaluation of CD14 in host defense. Eur J Clin Invest 2000; 30:167-169.
4. Schutt C: Molecules in focus: CD14. Int J Biochem Cell Biol 1999; 31:545-549.
5. Baldini M, Lohmann I, Halonen M, Erickson R, Holt P, Martinez F: A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20:976-983.
6. Hubacek J, Pit'ha J, Skodova Z, Dtanek V, Poledne R: C(-260) T polymorphism in the promoter region of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999; 99:3218-3220.
7. Unkelbach K, Gardemann A, Kostrewa M, Philipp M, Tillmanns H, Haberbosch W: A new promotor polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol 1999; 19:932-938.
8. Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, Eitner K, Marx M, Duering N, Epplen J: A polymorphism in the CD14 gene is associated with Crohn's disease. Scand J Gastroenterol 2002; 37:189-191.
9. Lennard-Jones J: Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; 170:2-6.
10. Miller S, Dykes D, Polesky H: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215.
11. Mohamed N, Rainier T, Ross J: Experimental study of receptor-mediated bacterial adhesion under the influence of fluid shear. Biotechnol Bioengenir 2000; 68:628-636.
12. Hugot J, Thomas G: Genome-wide scanning in inflammatory bowel disease. Dig Dis 1998; 16:354-369.
13. Russel M, Pastoor C, Janssen K, van Deursen C, Muris J, van Wijlick E, Stockbrugger R: Familial aggregation of inflammatory bowel disease: a population-based study in South Limburg, The Netherlands. The South Limburg IBD Study Group. Scand J Gastroenterol 1997; 223:88-91.
14. Simmons D, Tan S, Tenen D, Nicholson-Weller A, Seed B: Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood 1989; 73:284-289.
15. Haziot A, Chen S, Ferrero E, Low M, Silber R, Goyert S: The monocyte differentiation antigen, CD14, is anchored to the cell membrane by phosphatidylinositol linkage. J Immunol 1988; 141:547-552.
16. Stelter F, Pfister M, Bernheiden M, Jack R, Bufler P, Engelmann H, Schutt C: The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms. Eur J Biochem 1996; 236:457-464.
17. Aderem A, Ulevitch R: Toll-like receptors in the induction of the innate immune response. Nature 2002; 406:782-787.
18. Chow J, Young D, Golenbock D, Christ W, Gusovsky F: Toll-like receptor-4 mediates lipopolyssacharide-induced signal transduction. J Biol Chem 1999; 274:10689-10692.
19. Frey E, Miller D, Jahr T, Sundan A, Bazil V, Espevik T, Finlay B, Wright S: Soluble CDU parcipitates in the response of cells to lipopolyssacharide. J Exp Med 1992; 176:1665-1671.
20. Pugin J, Schurer-Maly C, Leturcq D, Moriarty A, Ulevitch R, Tobias P: Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci 1993; 90:2744-2748.
21. Grunwald U, Kruger C, Schiatt C: Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function. Circ Shock 1993; 39:220-225.
22. Tapping R, Tobias P: Cellular binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS-binding protein. J Biol Chem 1997; 272:23157-23164.
23. Ebong S, Goyert S, Nemzek J, Kim J, Bolgos G, Remick D: Critical role of CD14 for production of proinflammatory cytokines and cytokine inhibitors during sepsis with failure to alter morbidity or mortality. Infect Immun 2001; 69:2099-2106.
24. Canning M, Grotenhuis K, de Wit H, Drexhage H: Opposing effects of dehydroepiandrosterone and dexamethasone on the generation of monocyte-derived dendritic cells. Eur J Endocrinol 2000; 143:687-695.
25. Devitt A, Moftatt O, Raykundalia C, Capra J, Simmons D, Gregory C: Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998; 392:505-509.
26. Miller A, Lider O, Roberts A, Sporn M, Weiner H: Suppressor T cells generated by oral tolerisation to myelin basic protein suppress both in vitro and in vivo immune response by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci 1992; 98:421-425.
27. Duchmann R, Neurath M, Marker H, Meyer zum Buschenfelde K: Immune response towards intestinal bacteria - current concepts and future perspectives. Z Gastroenterol 1997; 35:337-346.
28. Greenbloom S, Steinhart A, Greenberg G: Combination ciprofloxacin and metronidazole for active Crohn's disease. Can J Gastroenterol 1998; 12:53-56.